Blanket Purchase Agreement HT001415A0002

This Blanket Purchase Agreement awarded by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 2 provides for the delivery of radiometer blood gas testing reagents on two separate occasions. Radiometer America, Inc. is the prime contractor obligated to deliver $39,171.63 worth of reagents by January 31, 2023 and an additional $22,786.94 worth of reagents by August 24, 2022. Both orders are firm fixed price and contain reagents to support blood...

The Defense Health Agency has awarded a single-award Blanket Purchase Agreement (BPA) contract to Polyscientific Research and Development Corporation, a leading manufacturer of chemicals, stains, and reagents for in vitro diagnostic testing. The $8 million BPA contract, with a period of performance through September 2026, provides the agency with an efficient mechanism to procure a wide range of reagents and consumable supplies to support its medical testing and research programs. Specific...

The Department of Veterans Affairs Veterans Health Administration has awarded Roche Diagnostics Corporation, doing business as Roche Diagnostics Corp, a single-award indefinite delivery contract (IDC) to provide Roche brand reagents and consumables. The $100,685.04 firm fixed price delivery order has a period of performance through February 2027 and does not utilize any set-asides. Roche Diagnostics Corp, a foreign-owned for-profit manufacturer, is an established federal contractor that has...

The Department of Veterans Affairs (VA), Veterans Integrated Service Network 1 (VISN1), has awarded a single-award Blanket Purchase Agreement (BPA) to Fisher Scientific Company L.L.C. (doing business as Fisher Scientific) for the delivery of GENEXUS REAGENTS. The $6,381,461.95 BPA, which has a period of performance from February 1, 2025, to January 31, 2030, will serve as an indefinite delivery vehicle (IDV) for the VA to procure specialized reagents, supplies, and equipment required for its...

Abbott Laboratories Inc., through its Abbott Diagnostics Division, has been awarded an indefinite delivery contract by the Defense Health Agency to provide immunochemistry reagents. The contract has a potential value of $3.78 million and a period of performance through September 2023. Task orders issued to date include a $1.4 million order for the Defense Health Agency and orders valued at $1.89 million and $1.2 million for the Department of the Army Medical Command. Performance will take...

This indefinite delivery contract was awarded by the U.S. Food and Drug Administration (FDA), a civilian agency, to Roche Diagnostics Corporation, a global manufacturer of in vitro diagnostics, laboratory instruments, reagents, and associated products and services. The $6 million single-award IDC, which runs through September 2014, enables the FDA to acquire Roche's reagents, test kits, and other medical equipment and consumables on an as-needed basis through a series of fixed-price delivery...

This Indefinite Delivery Contract (IDC) was awarded by the Department of Veterans Affairs (VA) Network Contracting Office 9 to Roche Diagnostics Corporation, a manufacturer of in vitro diagnostics, reagents, and laboratory equipment. The contract, valued at $470,851.70, is for the delivery of Roche HE600 reagents over a period ending on September 30, 2029. This delivery order is part of a larger IDC held by Roche to supply chemistry reagents to VA and military treatment facilities across a...

This indefinite delivery contract (IDC) was awarded by the U.S. Department of Veterans Affairs (VA), through its Veterans Integrated Service Network 17, to Roche Diagnostics Corporation for the provision of Roche Ventana reagents and consumables. Roche Diagnostics, a manufacturer and distributor of in vitro diagnostics, has provided critical care analyzers, reagents, test kits, and associated laboratory equipment and supplies to various federal agencies, including the VA, Department of...

Roche Diagnostics Corporation was awarded a single-award indefinite delivery contract by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 10. The contract has a potential value of $1,115,564.58 to provide reagents and supplies with no set-aside designation. Performance will take place through January 31, 2028. Under this contract, Roche Diagnostics was issued a $210,121.69 firm fixed price delivery order for reagents and supplies. The delivery...

The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 1 awarded Roche Diagnostics Corporation an indefinite delivery contract for reagents. The IDV has a potential value of $700,000 and a period of performance through September 1, 2027. No set-aside was used. Under the IDV, Roche Diagnostics has received multiple delivery orders for reagents to support medical testing programs across VISN 1 facilities. Delivery orders ranged in value from...